Study of Efficacy and Safety of Investigational Treatments in Patients With Moderate to Severe Hidradenitis Suppurativa
Public ClinicalTrials.gov record NCT03827798. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Subject and Investigator Blinded, Placebo-controlled and Multi-center Platform Study, to Assess Efficacy and Safety of Different Investigational Drugs in Patients With Moderate to Severe Hidradenitis Suppurativa
Study identification
- NCT ID
- NCT03827798
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Novartis Pharmaceuticals
- Industry
- Enrollment
- 248 participants
Conditions and interventions
Conditions
Interventions
- CFZ533 Drug
- Placebo to CFZ533 Drug
- LYS006 Drug
- Placebo to LYS006 Drug
- MAS825 Drug
- Placebo to MAS825 Drug
- LOU064 25mg Drug
- LOU064 100mg Drug
- Placebo to LOU064 Drug
- VAY736 Drug
- Placebo to VAY736 Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 26, 2019
- Primary completion
- Dec 3, 2024
- Completion
- Dec 10, 2026
- Last update posted
- Feb 5, 2026
2019 – 2026
United States locations
- U.S. sites
- 8
- U.S. states
- 6
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Olympian Clinical Research | Clearwater | Florida | 33609 | — |
| Park Avenue Dermatology PA | Orange Park | Florida | 32073 | — |
| University Of South Florida | Tampa | Florida | 33612 | — |
| Advanced Medical Research | Sandy Springs | Georgia | 30328 | — |
| NorthShore University Health System | Evanston | Illinois | 60201 | — |
| Dawes Fretzin Clinical Rea Group | Indianapolis | Indiana | 46256 | — |
| Penn State Milton S Hershey Medical Center | Hershey | Pennsylvania | 17033-0850 | — |
| Medical University of South Carolina MUSC | Charleston | South Carolina | 29425 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 28 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03827798, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 5, 2026 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03827798 live on ClinicalTrials.gov.